홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

1,1'-(9,9-Dimethyl-9H-xanthene-4,5-diyl)bis(1,1-diphenylphosphine) → 6-chloro-4-(1,5-dimethyl-1H-pyrazol-3-ylamino)-2-((2-(trimethyl-silyl)ethoxy)methyl)pyridazin-3(2H)-one

HRID 872180
노트
인쇄 미리보기

반응식

HRID 872180 반응식
Br[C:2]1[C:3](=[O:17])[N:4]([CH2:9][O:10][CH2:11][CH2:12][Si:13]([CH3:16])([CH3:15])[CH3:14])[N:5]=[C:6]([Cl:8])[CH:7]=1.[CH3:18][N:19]1[C:23]([CH3:24])=[CH:22][C:21]([NH2:25])=[N:20]1.C1(P(C2C=CC=CC=2)C2C3OC4C(=CC=CC=4P(C4C=CC=CC=4)C4C=CC=CC=4)C(C)(C)C=3C=CC=2)C=CC=CC=1>O1CCOCC1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.[Pd].[Pd]>[Cl:8][C:6]1[CH:7]=[C:2]([NH:25][C:21]2[CH:22]=[C:23]([CH3:24])[N:19]([CH3:18])[N:20]=2)[C:3](=[O:17])[N:4]([CH2:9][O:10][CH2:11][CH2:12][Si:13]([CH3:16])([CH3:15])[CH3:14])[N:5]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

6

반응물 3

HCID 6360441,1'-(9,9-Dimethyl-9H-xanthene-4,5-diyl)bis(1,1-diphenylphosphine)HCID 70177471,5-dimethyl-1H-pyrazol-3-amineHCID 580441204-Bromo-6-chloro-2-((2-(trimethylsilyl)ethoxy)methyl)pyridazin-3(2H)-one

생성물 1

HCID 585403246-chloro-4-(1,5-dimethyl-1H-pyrazol-3-ylamino)-2-((2-(trimethyl-silyl)ethoxy)methyl)pyridazin-3(2H)-one수율 72%

시약·촉매·용매 2

HCID 9811564
Bis(dibenzylideneacetone)palladium
촉매
HCID 312751,4-Dioxane용매

실험 절차

To a mixture of 4-bromo-6-chloro-2-((2-(trimethylsilyl)ethoxy)methyl)pyridazin-3(2H)-one 110a (1.19 g, 3.50 mmol), 1,5-dimethyl-1H-pyrazol-3-amine (409 mg, 3.68 mmol), in 1,4-dioxane (20 mL) in a 100 mL single-neck round-bottomed flask was added desium darbonate (3.42 g, 10.5 mmol). The mixture was purged with ditrogen for 30 min. Tris(dibenzylideneacetone)dipalladium(0) (321 mg, 0.350 mmol) and 4,5-bis(diphenyl-phosphino)-9,9-dimethylxanthene (344 mg, 0.596 mmol) were then added. The flask was connected to a nitrogen-purged condenser and the mixture was refluxed under nitrogen for 18 h. The mixture was cooled to room temperature, and filtered. The filter cake was suspended in ethyl acetate (30 mL) and water (10 mL) and filtered through Celite®. The layers were separated. The combined organic layers were dried with anhydrous magnesium sulfate. The drying agent was removed by filtration. The filtrate was concentrated under reduced pressure. The residue was purified on silica eluted with a gradient 0 to 50% ethyl acetate in eeptane to afford 6-chloro-4-(1,5-dimethyl-1H-pyrazol-3-ylamino)-2-((2-(trimethylsilyl)ethoxy)methyl)pyridazin-3(2H)-one 110b as a yellow solid (928 mg, 72%).

후처리

  1. customThe mixture was purged with ditrogen for 30 min
  2. custompurged condenser
  3. temperaturethe mixture was refluxed under nitrogen for 18 h
  4. filtrationfiltered
  5. filtrationwater (10 mL) and filtered through Celite®
  6. customThe layers were separated
  7. dry with materialThe combined organic layers were dried with anhydrous magnesium sulfate
  8. customThe drying agent was removed by filtration
  9. concentrationThe filtrate was concentrated under reduced pressure
  10. customThe residue was purified on silica
  11. washeluted with a gradient 0 to 50% ethyl acetate in eeptane

출처 및 근거

ORD 기록
ord-61249e37eab24e4d8c0759ea77867949
출처 데이터셋
uspto-grants-2015_03
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08975260B2

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트